Manchester score

From WikiMD's Food, Medicine & Wellness Encyclopedia

Manchester Score is a clinical prediction rule for the diagnosis of gynecological cancer. It was developed by the researchers at the University of Manchester and is used to predict the likelihood of endometrial cancer in women presenting with postmenopausal bleeding (PMB).

Overview[edit | edit source]

The Manchester Score is calculated based on the following factors: age, body mass index (BMI), diabetes, hypertension, endometrial thickness, and bleeding pattern. Each factor is assigned a score, and the total score is used to predict the likelihood of endometrial cancer.

Calculation[edit | edit source]

The Manchester Score is calculated as follows:

  • Age: 1 point for each year over 50
  • BMI: 1 point for each unit over 25
  • Diabetes: 20 points
  • Hypertension: 20 points
  • Endometrial thickness: 1 point for each millimeter
  • Bleeding pattern: 20 points for PMB

The total score is then used to predict the likelihood of endometrial cancer. A score of less than 200 indicates a low risk, a score of 200-500 indicates a moderate risk, and a score of over 500 indicates a high risk.

Clinical Use[edit | edit source]

The Manchester Score is used in clinical practice to guide the management of women presenting with PMB. It helps to identify those at high risk of endometrial cancer who may benefit from further investigation and treatment.

Limitations[edit | edit source]

While the Manchester Score is a useful tool, it is not perfect. It does not take into account all possible risk factors for endometrial cancer, and it may not be accurate in all cases. Therefore, it should be used in conjunction with other clinical information and diagnostic tests.

See Also[edit | edit source]

Manchester score Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD